DigitalHealth InvestorTalk Show

Can telehealth deliver more than just convenience and bust healthcare out of the productivity trap?

Telehealth is no longer just about technology or convenience. It's about supporting every step of care delivery and creating new care models.

In this show we’ll look at:

• The current state of the art for telehealth and the way forward
• The ongoing hospital budget shock and how this creates a new moment for telehealth
• The productivity trap that healthcare has been stuck in for 75 years and the way out

And we'll answer your questions.

Chris Gallagher, MD, is the CEO of Teos Health and former CEO of Access TeleCare, one of the counrty's largest acute care telemedicine providers. He is nationally recognized for pineering virtual care programs including the first virtual cardiac arrest management program.

Steven Wardell is the Managing Partner of Wardell Advisors, a consulting firm focused on growth, fundraising, and strategic alternatives for digital health companies. He is the host of DigitalHealth InvestorTalk and the author of The Future of Digital Health. Follow for digital health insights at X.com/StevenWardell.

Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com.

Subscribe to the podcast!

Apple Podcasts: https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633

Spotify: https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ

This event is co-hosted with Boston Health Innovation Night and AgeTech Boston.

Our Guest of Honor, Kate Brigham, founder of AgeTech Boston, will make opening remarks on the theme of "What's Next in AgeTech."

Thur. Sept. 17, 2026 at the Liberty Hotel in Boston (the Panopticon).

In healthcare, the software that people use is now fighting the AI underneath it for the same prize: the customer, the data, and the future.

The next decade of competitive advantage will be decided by who controls the software layer between people and AI. Most companies haven’t noticed that the fight has started.

This show draws on the argument: when software disappears into intent, advantage shifts to whoever owns the defaults, the memory, and the trust.

For thirty years technology shifts have reshaped who wins. This time, the shift is different. AI agents don’t wait to be asked. They anticipate, orchestrate, and act. When software disappears into intent, the old questions stop mattering. Which app? Which vendor? Which features? Wrong questions. The real question is who owns the defaults, the memory, and the trust.

In this show we’ll look at:

• The healthcare data arenas like EMR data, clinical trial data, and patient reported data
• The strategies of the AI hyperscalers versus the human-facing software layer
• How this struggle will play out, who wins, and who loses.

And we’ll take your questions.

Harry Glorikian is a General Partner at Scientia Ventures and a Research Affiliate at the MIT Media Lab, where his work focuses on how AI rewrites competitive strategy and governance for lasting advantage. For more than three decades he has built, invested in, and advised companies at the convergence of healthcare, life sciences, and data-driven technology. His new book, The Invisible Interface: How AI Turns Intentions into Actions - and Who Wins (foreword by Don Norman), maps exactly this fight.

Steven Wardell is the Managing Partner of Wardell Advisors, a consulting firm focused on growth, fundraising, and strategic alternatives for digital health companies. He is the host of DigitalHealth InvestorTalk and the author of The Future of Digital Health. Follow for digital health insights at X.com/StevenWardell.

Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com.

Subscribe to the podcast!

Apple Podcasts: https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633

Spotify: https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ

Pharmaceutical manufacturers spend more than $40B annually on advertising and promotion, patient services, and Hubs. Only about 3% of Americans are even aware they offer resources like co-pay assistance and patient support programs. Little surprise then that between 20% to 30% of prescriptions are never filled.

Emerging AI-powered advocates are now available 24/7 to patients and healthcare providers via the phone, SMS, and web, significantly reducing friction and streamlining the path to therapy. Imagine patient journeys orchestrated by personal concerges that can

• Answer any medication-related question
• Verify insurance benefits, both Rx and medical
• Find and schedule doctor appointments
• Track down prior authorizations
• Autonomously enroll patients in affordability programs

That doesn't just translate into higher levels of engagement, but it also results in higher levels of medication compliance and suppports better condition management through longer-term adherence. And it's producing more informed patients -- another step toward healthcare consumerism.

The patient journey is often frustrating to patients who have difficulties using benefits and staying on therapy. AI changes that.

In this show we'll look at the new age promised by AI, when a patient concierge becomes smart and often free:

• Navigating the patient to the right benefits
• Getting the patient on the right therapy and keeping them adherent
• Solving the frictions of the healthcare system.

And we’ll answer your questions.

Sage Khanuja is a Seattle Inno Under 25 honoree as well as the co-founder and President of The RXAssistant (therxassistant.com). Prior to launching the company in 2024, he founded and sold Spira, a no-code telehealth solution, to Galileo.

Steven Wardell is the Managing Partner of Wardell Advisors, a consulting firm focused on growth, fundraising, and strategic alternatives for digital health companies. He is the host of DigitalHealth InvestorTalk and the author of The Future of Digital Health. Follow for digital health insights at X.com/StevenWardell.

Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com.

Subscribe to the podcast!

Apple Podcasts: https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633

Spotify: https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ

Hormones, Biomarkers, and the End of Annual Lab Work: Empowered consumers monitor hormone levels & more from home to optimize their health.

Health tracking used to mean episodic visits to the clinician, followed by tests to rule out what could be wrong. But today, a growing range of at-home monitoring tools, more convenient and affordable than ever, lets consumers track their hormone levels and other key biomarkers continuously, moving from ruling out illness to actively optimizing their health and vitality.

In this show we’ll look at:

• The new paradigm of consumer home testing and empowerment and what is enabling it.
• Tests that are becoming more available and how they can support your health and wellness
• A deep dive on hormones including hormone monitoring, hormone replacement therapy, and options for perimenopausal women.
• Why hormones are the missing data layer in longevity, and what continuous monitoring could reveal that annual lab work cannot.

Shilpi Gupta is the founder and CEO of Qyn Labs, a hormone-health company developing at-home, real-time hormone monitoring with a focus on helping women navigate transitions like perimenopause. Before founding Qyn, she helped scale Roomba from a $100M to a $1B business at iRobot and led robotics product development at Amazon.

Steven Wardell is the Managing Partner of Wardell Advisors, a consulting firm focused on growth, fundraising, and strategic alternatives for digital health companies. He is the host of DigitalHealth InvestorTalk and the author of The Future of Digital Health. Follow for digital health insights at X.com/StevenWardell.

Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com.

Subscribe to the podcast!

Apple Podcasts: https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633

Spotify: https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ

Marketing is about meeting customers' needs. But how do we do this with a changing landscape and what if the customer is an AI agent?

The marketing landscape is changing dramatically. Customers may go to an AI chatbot for answers instead of a search engine, obseleting SEO and ads from vendors in one shot. And what if the customer you're really selling to is an AI agent?

In this show we’ll look at:

- What are modern AI SEO, AI search, and AI marketing?

- How do you get your product into a chatbot's answer?

- How do you get chosen by AI agents?

And we’ll take your questions.

Dale Bertrand is an SEO strategist and founder & CEO of Fire&Spark agency.

Noah Goldfarb is the founder of the Digital Health Growth Mastermind and a director at Fire& Spark agency.

Steven Wardell is the Managing Partner of Wardell Advisors, a consulting firm focused on growth, fundraising, and strategic alternatives for digital health companies. He is the host of DigitalHealth InvestorTalk and the author of The Future of Digital Health. Follow for digital health insights at X.com/StevenWardell.

Digital is a high-potential modality in therapeutics but 10 years later there are few hit products. What can we expect next?

In this show we'll cover:

• Successes and challenges of Prescription Digital Therapeutics 1.0
• Will PDTs achieve parity with molecular therapeutics?
• What are the current enablers and blockers of better care through digital therapeutics?

And we'll answer your questions.

Eddie Martucci, PhD, is the CEO of Alterris Oncology, a cancer biotech company; Advisor and President (US) of ResilienceCare, a digital health company in oncology care; and was the founding CEO of Akili Interactive, the leading prescription digital therapeutics company. Eddie also serves as a venture advisor to Sofinnova Partners, is on the Program Advisory Board of the MD Anderson Cancer Center's Cancer Neuroscience Program, and advises select founder-led early-stage innovative startup companies through his consulting firm, Martucci Innovations. Eddie has been named a Business Insider 30 Under 40 in Healthcare, and in 2021 was featured as one of Newsweek's "America's 50 Greatest Disruptors."

Steven Wardell is the Managing Partner of Wardell Advisors, a consulting firm focused on growth, fundraising, and strategic alternatives for digital health companies. He is the host of DigitalHealth InvestorTalk and the author of The Future of Digital Health. Follow for digital health insights at X.com/StevenWardell.

Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com.

Subscribe to the podcast!

Apple Podcasts: https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633

Spotify: https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ

In this show we'll cover:

• What telehealth has meant up to now
• How patients, clinicians, technology, and care delivery have changed
• A new vision of telehealth

And we'll answer your questions.

Lyle Berkowitz, MD, is the founder and Executive Chairman of KeyCare, a network of AI tech-enhanved virtual care providers working on an instance of Epic optimized for telehealth. Follow him on LinkedIn.

Steven Wardell is the Managing Partner of Wardell Advisors, a consulting firm focused on growth, fundraising, and strategic alternatives for digital health companies. He is the host of DigitalHealth InvestorTalk and the author of The Future of Digital Health. Follow for digital health insights at X.com/StevenWardell.

Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com.

There's been massive innovation and entry into the Employer HealthTech sector and now consolidation is playing out. The endgame is near.

The right combination of health benefits provided by employers can attract and retain talent, build company identity and morale, promote better health and productivity among employees, and bend the medical cost trend downward over time. So for over 20 years employers have been picking and providing innovative mixes of healthcare and programmatic health benefits to employees to earn these advantages. And the market has responded with massive entry of new products, talent, companies, and investment capital.

Now we're seeing emergent winners and losers, changing buyer preferences, maturity of the sector, aggregation of services, and the uptick of consolidation in the industry.

In this show we'll cover:

- The story of the employer healthtech thus far

- Market maturation, changing buyer preferences

- The uptick in consolidaiton and what's next

And we'll answer your questions.

Chris Michalak is the Executive Chairman and former CEO of Personify Health, the leading provider of navigation, wellness, and care management solutions to employers, and he is the former CEO of Buck Consultants.

Steven Wardell is the Managing Partner of Wardell Advisors, a consulting firm focused on growth, fundraising, and strategic alternatives for digital health companies. He is the host of DigitalHealth InvestorTalk and the author of The Future of Digital Health. Follow for digital health insights at X.com/StevenWardell.

The amount of healthcare data keeps growing. The tools we have keep improving, including new GenAI tools.

But to truly drive better healthcare outcomes, we need to improve the agency of both patients in healthcare systems and of consumers at home.

In this show we'll cover:

- The new landscape of data and tools in healthcare

- Extracting meaningful insight for care delivery

- Using GenAI and digital tools to drive behavior change and improved health

And we'll answer your questions.

David Shaywitz, MD, PhD, is Chief Medical Scientist at Lore Health.

Steven Wardell is the Managing Partner of Wardell Advisors, a consulting firm focused on growth, fundraising, and strategic alternatives for digital health companies. He is the host of DigitalHealth InvestorTalk and the author of The Future of Digital Health. Follow for digital health insights at X.com/StevenWardell.